The Special Olympics EU Eurasia Foundation (SOEEF) is dedicated to providing critical services to children and adults with intellectual disabilities through ongoing training and competition, physical activities, inclusive sport, social inclusive initiatives and health services in all 28 Member States. The objectives are to offer quality training, competition, health screenings, and ongoing inclusive opportunities to athletes to maximize individual athlete potential, promote health and a healthy lifestyle both in sport and daily life, whilst reducing health inequalities and improving access to quality health services for people with intellectual disabilities.
In summary we can point out that people with intellectual disabilities have a wide range of chronic and acute health issues and conditions. In many instances, more frequent and severe symptoms than the general population; are twice as likely to have significant visual problems and at much younger age; are hardly ever engaged in vigorous physical activity and find it difficult to make themselves understood when speaking with health professionals; health conditions are may be similar to the general population, the impacts can be greater on those with ID; Experience higher mortality rates as a result of higher rates of cardiovascular diseases. Special Olympics EU Eurasia and its partner national programs provides its service to almost half a million individuals with intellectual disabilities across the EU driven mainly by volunteers.
The Healthy Athletes (HA) program provides access to health care for SO Athletes not only to improve their ability to improve health and fitness levels or to train and compete in SO events, but also to identify health care needs and to improve quality of health care for people with intellectual disabilities. The integrated health and physical activity action plan improves public health and reduces health inequalities of people with intellectual disabilities.


Under its leading motto for the Framework Partnership Agreement, continuity and innovation, AIDS Action Europe (AAE) will maintain to work in 2017. As a comprehensive NGO network in the field of HIV/AIDS with over 400 network members and partners AAE is a unique player with substantial added value for European policy making and programme implementation. Based on the problem analysis and the activities implemented in 2015 and 2016, AAE will focus on tackling following core problem areas in 2017:
Advocacy for a new policy framework
Advocacy for European issues at the international level
Upscaling access to prevention for gay men and other MSM
Improved access to HIV services for all those whose access is limited due to their residency status
Affordability of medicines and access to treatment
Community based voluntary counselling and testing (CBVCT) outside medical settings
and tackling stigma and discrimination
Within Objective I, AAE will ensure that Civil Society’s voices are being heard and key populations’ needs are addressed by organising the EU HIV/AIDS CSF, contributing to the Think Tank, contributing to key European events and participating in the UNAIDS PCB. Furthermore AAE will continue its activities regarding undocumented migrants, affordability of medicines, promoting CBVCT and upscaling access to prevention for gay men and other MSM. Tackling stigma and discrimination is a core task for AAE and is reflected as a cross sectional theme in all our activities. AAE will advocate for the rights of key populations and contribute to fairer, inequality reducing societies. Under Objective II communication and collaboration, facilitate linking and learning between members and partners are at focus with a recently re-launched and re-designed AAE Clearinghouse and website as well as through our social media presence. Objective III will ensure overall governance, the functioning of the network and the implementation of the annual work programme.



The European Organisation for Rare Diseases (EURORDIS) is the voice of 30 million people affected by rare diseases throughout Europe.

EURORDIS is a non-governmental patient-driven alliance of organisations and individuals active in the field of rare diseases in Europe.

EURORDIS represents 716 rare disease patient organisations in 63 countries out of which 27 EU member states, covering more than 4000 rare diseases and rare cancers.

EURORDIS advocates for people living with rare diseases, fosters patient engagement in Commission Expert Groups, at the European Medicines Agency and EUnetHTA, provides services to patients such as information, networking and capacity building on all aspects of their condition such as therapeutic developments, access to medicines, social services and healthcare. This is done through tools such as the eurordis.org website, Summer School, Rare Disease Day, RareConnect.org , the survey programme Rare Barometer Voices, Rare Diseases International and the European Conference on Rare Diseases & Orphan Products.

The EURORDIS Specific Grant Agreement 2017 continues the work of SGA 2016 within the overarching Framework Partnership Agreement 2015-2017. This grant's main strategic objectives are to consolidate the rare disease patient community and strengthen the voice of rare disease patients; to actively engage rare disease patient representatives to contribute to the adoption, effective implementation and monitoring of relevant EU legislation/strategies and support their integration at national level; to build capacities and empower rare disease patients advocates, members and volunteers; to sustain human, financial and organisational resources.

